Filing Flows › Comparisons › TFX vs ICUI
Teleflex vs ICU Medical: TFX and ICUI compared
Teleflex is the larger company: $568M of revenue in its latest quarter (Q3 2026) against $560M for ICU Medical (Q3 2026). ICU Medical is growing faster (+4% against +0.1% a year earlier). Teleflex is more profitable, with an operating margin of 18.6% against 9.3%.
Where the money goes: TFX and ICUI
Teleflex (TFX) · Q3 2026
Teleflex, Q3 2026: revenue $568M (+0.1% year over year), operating margin 18.6%, net earnings $927M, operating cash flow $96.3M. The chart follows the revenue to costs, profit and cash.
ICU Medical (ICUI) · Q3 2026
ICU Medical, Q3 2026: revenue $560M (+4% year over year), operating margin 9.3%, net earnings $26.8M, operating cash flow $99.6M. The chart follows the revenue to costs, profit and cash.
| Teleflex (TFX) | ICU Medical (ICUI) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $568M | $560M |
| Revenue growth, Y/Y | +0.1% | +4% |
| Gross margin | 65.0% | 41.9% |
| Operating margin | 18.6% | 9.3% |
| Net earnings | $927M | $26.8M |
| Net margin | 163.3% | 4.8% |
| Operating cash flow | $96.3M | $99.6M |
| Free cash flow | $74.7M | $83.4M |
| Market value | $6.3B | $4.3B |
| P/E | 71.6× | — |
| Analysts’ mean target | $159.54 | $193.38 |
Where the revenue comes from
Teleflex
- Vascular: $243M (43%)
- Interventional: $210M (37%)
- Surgical: $114M (20%)
ICU Medical
- Infusion Consumables: $298M (53%)
- Infusion Systems: $193M (34%)
- Vital Care: $69.5M (12%)
Questions
Which is bigger, Teleflex or ICU Medical?
Teleflex is the larger company: $568M of revenue in its latest quarter (Q3 2026) against $560M for ICU Medical (Q3 2026).
Is Teleflex or ICU Medical growing faster?
ICU Medical is growing faster (+4% against +0.1% a year earlier).
Which is more profitable, Teleflex or ICU Medical?
Teleflex is more profitable, with an operating margin of 18.6% against 9.3%.
More: Teleflex earnings · how Teleflex makes money · ICU Medical earnings · how ICU Medical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.